Legislation, regulation and policies issues of orphan drugs in developed countries from 2010 to 2016

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18450%2F18%3A50014673" target="_blank" >RIV/62690094:18450/18:50014673 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.jab.2018.04.002" target="_blank" >http://dx.doi.org/10.1016/j.jab.2018.04.002</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jab.2018.04.002" target="_blank" >10.1016/j.jab.2018.04.002</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Legislation, regulation and policies issues of orphan drugs in developed countries from 2010 to 2016

Popis výsledku v původním jazyce

The purpose of this study is to evaluate current legislative policies and regulations with respect to the use of orphan drugs, to emphasize strengths and weaknesses of these policies in the period of 2010-2016 in European countries, especially in relation to the objectives set by the European Council in 2009. This was done by the method of literature search in the databases PubMed, Scopus, ScienceDirect, and Web of Science from 2010 to 2016. The findings show a lack of polices for the appraisal and reimbursement of orphan drugs, a lack of uniform European legislation and different orphan drugs expenditure. (C) 2018 Faculty of Health and Social Sciences, University of South Bohemia in Ceske Budejovice. Published by Elsevier Sp. z o.o. All rights reserved.

Název v anglickém jazyce

Legislation, regulation and policies issues of orphan drugs in developed countries from 2010 to 2016

Popis výsledku anglicky

The purpose of this study is to evaluate current legislative policies and regulations with respect to the use of orphan drugs, to emphasize strengths and weaknesses of these policies in the period of 2010-2016 in European countries, especially in relation to the objectives set by the European Council in 2009. This was done by the method of literature search in the databases PubMed, Scopus, ScienceDirect, and Web of Science from 2010 to 2016. The findings show a lack of polices for the appraisal and reimbursement of orphan drugs, a lack of uniform European legislation and different orphan drugs expenditure. (C) 2018 Faculty of Health and Social Sciences, University of South Bohemia in Ceske Budejovice. Published by Elsevier Sp. z o.o. All rights reserved.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30304 - Public and environmental health

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of applied biomedicine

ISSN

1214-021X

e-ISSN

—

Svazek periodika

16

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

175-179

Kód UT WoS článku

000440056300003

EID výsledku v databázi Scopus

2-s2.0-85046370455